Riskpilot← Back to searchSign inGet full accessMentex AB
ABActiveOrg 5568208879Industrivägen 34Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20102 employees
Revenue 2025
SEK 7,2M
+7% vs 2024
EBITDA margin
17.0%
+15% vs 2024
Equity ratio
45.2%
Financial strength
Net profit 2025
SEK 636K
+26% vs 2024
| Revenue | SEK 7,2M | +7% |
| EBITDA | SEK 1,2M | +15% |
| Net profit | SEK 636K | +26% |
| Total assets | SEK 6,8M | +7% |
| Equity | SEK 3,1M | +12% |
| Employees | 2 | — |
Legal name
Mentex AB
Org number
5568208879
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
7 oktober 2010
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska utveckla och sälja terapihjälpmedel och pedagogiskt material samt bedriva utbildning inom dessa områden och därmed förenlig verksamhet.
Address
Industrivägen 34
Phone
+4691037002
Email
info@mentex.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 311 | 775 | 2 711 | 10 091 | 13 242 | 8 994 | 6 670 | 7 166 |
| Staff expenses | — | — | — | — | — | — | −1 456 | −1 596 | −1 332 | −1 560 |
| EBITDA | 31 | 33 | −11 | 15 | 308 | 1 592 | 2 539 | 2 238 | 1 055 | 1 219 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −12 | −216 | −216 | −216 | −149 | −142 |
| EBIT | 31 | 33 | −11 | 15 | 296 | 1 376 | 2 323 | 2 022 | 906 | 1 076 |
| Net financials | −8 | −8 | −8 | 1 | 342 | 23 | 97 | 13 | −31 | 9 |
| Profit before tax | 18 | 18 | 0 | 22 | 467 | 974 | 1 814 | 1 615 | 650 | 808 |
| Tax | −4 | −4 | −0 | −5 | −100 | −210 | −375 | −338 | −144 | −172 |
| Net profit | 14 | 14 | 0 | 17 | 367 | 764 | 1 439 | 1 277 | 506 | 636 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 629 | 650 | 555 | 683 | 1 926 | 4 526 | 7 040 | 7 050 | 6 393 | 6 813 |
| Equity | 160 | 174 | 174 | 191 | 558 | 1 322 | 2 761 | 3 038 | 2 744 | 3 080 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — |
| Short-term debt | 428 | 429 | 353 | 470 | 1 176 | 2 587 | 3 056 | 2 368 | 1 781 | 1 587 |
| Total debt | 428 | 429 | 353 | 470 | 1 176 | 2 587 | 3 056 | 2 368 | 1 781 | 1 587 |
EBITDA margin
17.0%
This company
15.8%
Market median
+8% vs market
20162025
Equity ratio
45.2%
This company
38.2%
Market median
+18% vs market
20162025
Return on equity
20.6%
This company
18.4%
Market median
+12% vs market
20162025
Net profit margin
8.9%
This company
8.1%
Market median
+10% vs market
20162025
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
20162025
Debt / equity
1.21×
This company
0.62×
Market median
-95% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TK | Audit | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mentex AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tage Kenneth Holmberg | Audit | 0 companies |
| Carin Therése Marklund | Board of Directors | 0 companies |
| Olov Marklund | Deputy Board Member | 0 companies |